Page last updated: 2024-09-03

ae0047 and Hypertension

ae0047 has been researched along with Hypertension in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (75.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kagitani, Y; Kawamura, T; Nagai, H; Narita, Y; Shinyama, H; Uchida, T; Watanabe, M1
Ebisu, H; Egi, Y; Fujino, Y; Hayashi, K; Inoue, S; Kido, H; Kubo, Y; Nakamura, N; Nishikawa, M; Ohtaki, Y; Uchida, T; Yamanaga, K1
Ebisu, H; Egi, Y; Hayashi, K; Kido, H; Kubo, Y; Nakamura, N; Nishikawa, M; Shinyama, H1
Egi, Y; Hayashi, K; Iwamoto, M; Kagitani, Y; Kido, H; Koyama, M; Kubo, Y; Nakamura, N; Shinyama, H1
Kagitani, Y; Kawamura, T; Nagai, H; Nakamura, N; Narita, Y; Shinyama, H1
Kido, H; Kubo, Y; Nakamura, N; Nakayama, T; Nishikawa, M1
Hayashi, K; Matsumura, Y1

Reviews

2 review(s) available for ae0047 and Hypertension

ArticleYear
Watanidipine. AE 0047, Calbren, GJ 0956, Vatanidipine.
    Drugs in R&D, 2002, Volume: 3, Issue:5

    Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Humans; Hyperlipidemias; Hypertension; Memory Disorders; Myocardial Ischemia; Rats

2002
Vatanidipine hydrochloride: a new long-lasting antihypertensive agent.
    Expert opinion on investigational drugs, 2001, Volume: 10, Issue:1

    Topics: Animals; Antihypertensive Agents; Arteriosclerosis; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Humans; Hypertension; Nitrendipine

2001

Other Studies

6 other study(ies) available for ae0047 and Hypertension

ArticleYear
Protective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:2

    Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Hemodynamics; Hypertension; Male; Rats; Rats, Inbred SHR

1995
[Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1997, Volume: 109, Issue:6

    Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Desoxycorticosterone; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Hypertension, Renal; Injections, Intravenous; Nicardipine; Nitrendipine; Rats; Rats, Inbred SHR

1997
[Antihypertensive effects of long-term treatment with AE0047, a novel long-lasting calcium antagonist, in hypertensive models of rats and dogs].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1997, Volume: 109, Issue:6

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiomegaly; Dihydropyridines; Dogs; Heart Rate; Hypertension; Hypertension, Renal; Male; Rats; Rats, Inbred SHR

1997
Preventative and therapeutic effects of AE0047 on renal injury in stroke-prone spontaneously hypertensive rats.
    Clinical and experimental pharmacology & physiology, 1997, Volume: 24, Issue:11

    Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Hypertension; Kidney Diseases; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY

1997
Effects of long-term treatment with the calcium antagonist AE0047 on cerebrovascular autoregulation and hypertrophy in spontaneously hypertensive rats.
    Journal of cardiovascular pharmacology, 1997, Volume: 30, Issue:5

    Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cerebral Arteries; Cerebrovascular Circulation; Dihydropyridines; Disease Models, Animal; Homeostasis; Hypertension; Hypertrophy; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY

1997
Protection against endothelial abnormalities by a novel calcium channel blocker, AE0047, in stroke-prone spontaneously hypertensive rats.
    General pharmacology, 1999, Volume: 32, Issue:3

    Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Endothelium, Vascular; Heart Rate; Hypertension; Male; Prostaglandins; Protective Agents; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction; Vasodilation

1999